No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
58 |
4. Check minimum number of eventsNone |
58 |
5. Include endpointsNone |
58 |
6. Filter based on genotype QC (FinnGen only) |
58 |
Control definitions (FinnGen only)
- Control exclude
- H8_MIDDLEMASTOID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H74
- Name in latin
- Polypus auris mediae
Similar endpoints
↥List of similar endpoints to
Polyp of middle ear
based on the number of shared cases.
Similar with more cases:
- Diseases of middle ear and mastoid
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 794 | 336 | 456 |
| Only index persons | 694 | 295 | 399 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 11.75 | 10.66 | 12.26 |
| Only index persons | 13.86 | 11.53 | 15.58 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 58 | 30 | 28 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 48.50 | 44.56 | 52.71 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019225) pH of Specimen
10
29
3.96
3.21
3.0
7.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
14
52
3.23
3.16
1.6
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
12
42
3.34
2.95
2.7
7.1
mmol/l
0.2
1.8
—
7
34
(3022313) Gas panel - Capillary blood
10
31
3.69
2.93
3.0
8.2
—
—
—
0
0
(3009343) pH of Capillary blood
12
43
3.26
2.85
2.7
7.0
—
7.5
—
0
6
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
13
5.01
2.33
1.3
2.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
12
49
2.83
2.28
5.9
4.4
%
37.1
33.3
—
7
24
(3004588) Protein electrophoresis panel - Serum or Plasma
8
27
3.27
2.02
3.3
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
11
46
2.72
1.99
3.8
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
11
4.86
1.98
1.2
2.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
17
3.81
1.89
4.0
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
8
29
3.03
1.87
2.5
2.2
ng/l
96.8
127.1
—
8
24
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
12
4.45
1.86
1.0
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
9
37
2.69
1.56
3.1
1.8
g/l
64.4
66.6
—
9
32
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
25
2.56
1.28
1.2
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
10
50
2.21
1.25
27.4
16.7
inr
1.5
1.2
—
5
11
(3044640) Blood type and Crossmatch panel - Blood
20
130
1.82
1.25
3.3
2.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
16
97
1.90
1.23
3.5
2.8
—
—
—
0
0
(3013512) EKG study
18
114
1.84
1.21
5.5
3.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
35
0.00
1.20
0.0
3.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
0
36
0.00
1.18
0.0
4.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
0
30
0.00
1.00
0.0
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
32
0.00
0.98
0.0
2.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
10
159
0.55
0.89
2.3
2.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
46
1.86
0.87
1.6
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
66
1.82
0.86
3.6
2.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
27
0.00
0.79
0.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
7
41
1.80
0.73
1.1
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
8
123
0.59
0.63
1.3
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
21
0.00
0.61
0.0
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
21
0.00
0.61
0.0
2.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
45
402
1.53
0.61
4.7
3.8
mmol/l
1.3
1.2
0.16
40
362
(3041096) Erythrocytes [Presence] in Urine by Automated
9
131
0.63
0.61
1.9
3.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
46
413
1.55
0.61
13.5
12.2
ml/min/173m2
82.0
83.7
0.18
40
328
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
34
1.85
0.61
3.3
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
65
1.65
0.60
1.5
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
33
279
1.42
0.59
7.7
9.3
e9/l
4.1
4.1
0.01
28
246
(40761511) CBC panel - Blood by Automated count
47
506
0.62
0.58
14.9
12.2
—
—
—
0
0
(3026782) Osmolality of Urine
6
97
0.57
0.58
2.2
3.0
mosm/kgh2o
457.5
547.0
—
6
85
(3042936) Bacteria identified in Isolate by Culture
9
60
1.59
0.58
2.0
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
61
1.56
0.57
3.1
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
38
1.64
0.56
3.5
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
46
417
1.50
0.53
5.2
4.2
mmol/l
1.5
1.5
0.39
39
376
(3020682) Albumin/Creatinine [Ratio] in Urine
17
130
1.44
0.52
4.5
3.3
mg/mmol
54.9
6.9
—
10
78
(3023368) Bacteria identified in Blood by Culture
15
112
1.46
0.51
4.1
4.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
16
122
1.43
0.49
3.9
2.8
mg/l
138.8
574.9
—
9
81
(3000850) Epithelial cells [#/volume] in Urine
7
101
0.65
0.44
2.1
2.4
e6/l
7.0
5.9
—
7
91
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
33
1.56
0.42
1.0
1.3
—
—
—
0
0
(4010399)
5
33
1.56
0.42
1.4
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
5
33
1.56
0.42
2.4
1.6
g/l
1.1
1.1
—
5
26
(42870588) Differential panel, method unspecified - Blood
20
163
1.35
0.42
4.0
6.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
20
163
1.35
0.42
2.0
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
0
15
0.00
0.42
0.0
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
16
0.00
0.42
0.0
1.4
—
320.8
—
0
7
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.42
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
16
0.00
0.42
0.0
6.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
35
310
1.33
0.41
2.9
4.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
9
124
0.68
0.40
1.2
3.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
15
186
0.74
0.39
2.4
4.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
10
73
1.45
0.37
1.5
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
46
1.34
0.34
1.3
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
32
285
1.27
0.34
3.1
4.3
—
53.2
—
0
5
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
45
419
1.33
0.32
5.0
4.3
mmol/l
4.7
4.6
0.34
40
382
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
46
431
1.33
0.30
5.5
4.8
mmol/l
2.7
2.7
0.23
39
393
(3018677) aPTT in Platelet poor plasma by Coagulation assay
5
71
0.68
0.28
2.4
2.5
s
26.6
28.7
—
5
71
(3035350) Ketones [Presence] in Urine by Test strip
20
230
0.80
0.28
2.5
4.0
—
0.0
—
0
39
(36304419) Bacteria [Presence] in Urine
10
126
0.75
0.28
2.8
3.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
42
445
0.80
0.25
15.2
15.7
%
35.8
39.6
0.92
30
335
(3018095) Leukocytes [#/volume] in Urine
14
166
0.79
0.25
3.6
3.7
e6/l
51.0
49.2
—
8
120
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
12
145
0.78
0.24
2.5
3.4
u/l
30.6
29.9
0.05
12
137
(3011397) Hemoglobin [Presence] in Urine by Test strip
13
107
1.28
0.24
2.5
3.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
107
1.28
0.24
1.7
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
5
38
1.34
0.24
2.2
2.1
g/l
8.6
9.5
—
5
31
(3021601) Nitrite [Presence] in Urine by Test strip
20
227
0.82
0.24
4.5
5.6
—
0.0
—
0
38
(46235355) HIV 1 and 2 tests - Meaningful Use set
11
89
1.29
0.23
1.7
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
5
42
1.21
0.22
4.0
4.4
ug/l
19.1
11.9
—
5
34
(3002582) Erythrocytes [#/volume] in Urine
12
143
0.80
0.22
2.7
3.1
e6/l
25.9
24.6
—
7
113
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
10
122
0.78
0.21
1.2
1.4
—
0.7
—
0
24
(3018418) pH of Serum or Plasma
10
122
0.78
0.21
4.3
3.4
—
7.4
—
0
20
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
47
1.31
0.21
1.5
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.4
—
129.6
—
0
5
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
41.4
—
0
14
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
58
1.23
0.19
1.0
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
59
1.21
0.19
3.3
9.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
69
1.18
0.17
1.1
1.4
—
—
—
0
0
(3015736) pH of Urine
16
181
0.84
0.17
2.4
3.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
21
231
0.86
0.16
2.6
4.1
—
0.0
—
0
39
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
42
400
1.18
0.16
6.9
5.5
mmol/mol
43.6
40.4
0.59
37
373
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
50
484
1.24
0.15
13.8
13.5
mg/l
19.9
23.9
0.40
41
374
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
35
330
1.15
0.15
2.8
3.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
18
166
1.12
0.09
5.2
4.0
ng/l
21.5
40.9
0.52
12
119
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
13
117
1.14
0.09
5.2
4.1
%
14.1
22.5
—
7
54
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
58
1.04
0.09
1.5
1.3
—
—
—
0
0
(3012544) pH of Venous blood
6
58
1.04
0.09
2.8
5.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
8
77
1.05
0.08
1.1
1.2
—
39.0
—
0
27
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
45
439
1.11
0.06
5.2
4.3
mu/l
2.2
1.9
0.83
39
395
(3024561) Albumin [Mass/volume] in Serum or Plasma
18
190
0.92
0.04
2.3
5.8
g/l
31.5
35.3
1.10
18
181
(3044889) 12 lead EKG panel
29
300
0.93
0.04
2.8
3.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
10
93
1.09
0.02
1.4
1.8
pmol/l
453.4
481.5
—
10
78
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
42
427
0.94
0.01
4.9
4.5
mmol/l
6.1
5.9
0.24
34
387
(3019150) Specific gravity of Urine by Refractometry
12
114
1.07
0.01
2.3
3.4
kg/l
1.0
1.0
—
5
16
(40758558) Short blood count panel - Blood
13
124
1.06
0.01
4.1
5.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
15
156
0.95
0.00
2.5
3.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
11
111
0.99
0.00
2.5
4.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
24
239
1.01
0.00
5.5
6.2
umol/l
9.3
15.4
2.03
24
224
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
34
344
0.97
0.00
4.8
3.8
pmol/l
14.5
14.9
0.28
29
314
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
16
156
1.04
0.00
2.5
1.8
pmol/l
89.3
94.2
—
6
78
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
20
198
1.02
0.00
5.3
4.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
15
152
0.98
0.00
1.6
3.1
mmol/l
2.3
2.4
—
9
133
(3024928) Oxygen saturation in Venous blood
0
6
0.00
0.00
0.0
8.7
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
254.0
—
0
6
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
0.3
—
0
6
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4027681)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
17.1
—
0
6
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
5
51
0.98
0.00
7.0
9.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010421) pH of Blood
0
8
0.00
0.00
0.0
2.4
—
7.4
—
0
8
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
37.4
—
0
5
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
8
0.00
0.00
0.0
2.4
—
8.9
—
0
8
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
5
0.00
0.00
0.0
1.2
—
188.9
—
0
5
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
3.8
—
290.9
—
0
5
(3014051) Protein [Presence] in Urine by Test strip
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.7
—
62.7
—
0
7
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
6.6
—
0
5
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
9.8
—
0
8
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
9
0.00
0.00
0.0
1.6
—
90.2
—
0
9
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
0.4
—
0
8
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.6
—
3.2
—
0
5
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
88.6
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.9
—
1.3
—
0
7
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
8
0.00
0.00
0.0
2.4
—
5.2
—
0
8
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
178.2
—
0
5
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
7
0.00
0.00
0.0
1.7
—
5.0
—
0
7
(3027456) Digoxin [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.1
—
0.9
—
0
7
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_POLYPMIDD and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have H8_POLYPMIDD.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: H8_POLYPMIDD – Polyp of middle ear
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data